Cx43-Associated Secretome and Interactome Reveal Synergistic Mechanisms for Glioma Migration and MMP3 Activation

• Published in: Frontiers in neuroscience Vol. 13; p. 143
• Main Authors: Aftab, Qurratulain, Mesnil, Marc, Ojefua, Emmanuel, Poole, Alisha, Noordenbos, Jenna, Strale, Pierre-Olivier, Sitko, Chris, Le, Caitlin, Stoynov, Nikolay, Foster, Leonard J, Sin, Wun-Chey, Naus, Christian C, Chen, Vincent C
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Research Foundation 19.03.2019; Frontiers; Frontiers Media S.A
• Subjects: ARK1B10; Cancer; Cell adhesion & migration; Cell cycle; Cell growth; Cloning; Connexin 43; Cytoskeleton; Extracellular matrix; Gelatinase; Gene expression; Glioblastoma; glioma; Glioma cells; Hypoxia; Life Sciences; Matrix metalloproteinase; Medical prognosis; Metalloproteinase; migration; MMP3; Neurobiology; Neurons and Cognition; Neuroscience; Osteopontin; Proteins; Proteolysis; Proteomics; Secretion; Secretome; Stromelysin 1; Tumors; Canada; ARK1B10; connexin43; osteopontin; MMP3; migration; glioma; gap junction; secretome
• ISSN: 1662-4548; 1662-453X; 1662-453X
• DOI: 10.3389/fnins.2019.00143

Extracellular matrix (ECM) remodeling, degradation and glioma cell motility are critical aspects of glioblastoma multiforme (GBM). Despite being a rich source of potential biomarkers and targets for therapeutic advance, the dynamic changes occurring within the extracellular environment that are specific to GBM motility have yet to be fully resolved. The gap junction protein connexin43 (Cx43) increases glioma migration and invasion in a variety of and models. In this study, the upregulation of Cx43 in C6 glioma cells induced morphological changes and the secretion of proteins associated with cell motility. Demonstrating the selective engagement of ECM remodeling networks, secretome analysis revealed the near-binary increase of osteopontin and matrix metalloproteinase-3 (MMP3), with gelatinase and NFF-3 assays confirming the proteolytic activities. Informatic analysis of interactome and secretome downstream of Cx43 identifies networks of glioma motility that appear to be synergistically engaged. The data presented here implicate ECM remodeling and matrikine signals downstream of Cx43/MMP3/osteopontin and ARK1B10 inhibition as possible avenues to inhibit GBM.